Highlights
Cochlear (COH) operates in the healthcare sector and is part of the S&P/ASX 200 (XJO)
The company manufactures implantable hearing devices used globally
Presence in more than fifty countries with thousands of employees worldwide
Cochlear (ASX:COH) is part of the healthcare sector and listed on the S&P/ASX 200 (XJO). The company focuses on hearing implants and related technologies. Founded in Sydney, Cochlear has grown into a recognised manufacturer of implantable hearing solutions, contributing to advancements in auditory health on a global scale.
Global Operations and Reach
Cochlear (ASX:COH) maintains a presence in more than fifty countries and employs thousands of people across its operations. The company’s products are used by medical professionals around the world. These include cochlear implants and related hearing solutions designed for a variety of auditory conditions.
Product Range and Applications
The product range developed by Cochlear (ASX:COH) covers several implantable systems. These are typically used to address different types of hearing loss. The company's devices are developed with a focus on compatibility, functionality, and integration with patient needs through close collaboration with medical institutions.
Manufacturing and Innovation
Cochlear (ASX:COH) maintains in-house manufacturing facilities and engages in ongoing research and development. Innovation in implant technology and software plays a role in its operations. The company’s engineering teams focus on developing devices with features aligned to medical requirements across diverse markets.
ASX 200 (XJO) Positioning
As a member of the S&P/ASX 200 (XJO), Cochlear (ASX:COH) represents a key healthcare component within Australia’s benchmark index. The company’s footprint in the medical device sector and its distribution scale contribute to its standing among ASX-listed healthcare stocks.